Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3.83KPrice to Sales
VS
Market
Sector
Industry
History
$ 17.38Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information
Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLYELL IMMUNOPHARMA INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LYEL - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 203.06M | 3.83K | $ 53K |
| 3/31/2025 | $ 119.49M | 2.06K | $ 58K |
| 12/31/2024 | $ 196.53M | 3.22K | $ 61K |
| 9/30/2024 | $ 340.65M | 5.41K | $ 63K |
| 6/30/2024 | $ 360.96M | 6.68K | $ 54K |
| 3/31/2024 | $ 647.55M | 9.52K | $ 68K |
| 12/31/2023 | $ 721.63M | 5.55K | $ 130K |
| 9/30/2023 | $ 566.71M | 11.68 | $ 48.5M |
| 6/30/2023 | $ 602.46M | 12.43 | $ 48.48M |
| 3/31/2023 | $ 604.05M | 7.17 | $ 84.19M |
Key Performance Insights, Last 5 Years
- LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, LYELL IMMUNOPHARMA INC's average P/S has been 2.44K.
- The median P/S for LYELL IMMUNOPHARMA INC during this period was 143.05
- LYELL IMMUNOPHARMA INC reached its highest P/S over the past 5 years at 9.52K.
- The lowest P/S recorded by LYELL IMMUNOPHARMA INC in the same timeframe 6.34
LYELL IMMUNOPHARMA INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for LYELL IMMUNOPHARMA INC is calculated as follows: Market Cap [ $ 0 ] / Revenues [ $ 7.76M ]
(=) P/S [ 0 ] LYEL - Price to Sales, Last 5 years
6.34
Minimum
Dec 31, 2022
9.52K
Maximum
Mar 31, 2024
2.44K
Average
143.05
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |